Clinakos is invited to present at Intellus Worldwide 2024 Summit
Clinakos Inc. is proud to announce that we have been invited by Intellus Worldwide to present at the Intellus Worldwide 2024 Summit being held in Lincolnshire, IL from April 9th through April 12. Along with our partners Chiesi Group and Real Chemistry, we will be presenting on “Leveraging AI/ML to Improve Marketing Effectiveness in Rare […]
Day 3 at MAPS 2024 in Puerto Rico
Medical Affairs Professional Society (MAPS) 2024 in Puerto Rico is already on Day 3! It has been an amazing conference. From meeting current clients to creating new relationships, it has been three days of engaging in conversations, creating new friendships while nurturing old ones, and last but not least, having fun. This gathering united Medical […]
Why is AI Important in Healthcare?
Why is AI important in Healthcare? The Clinakos Inc. team has been trying to answer this important question including from coverage at hashtag#jpm2024, hashtag#himss2024, and planned talks at Medical Affairs Professional Society (MAPS), Reuters Events Pharma USA 2024 and ISPOR—The Professional Society for Health Economics and Outcomes Research. Here are some of the reasons we […]
Clinakos Participated at MAPS Annual Conference
We are thrilled to announce that we will be participating at Medical Affairs Professional Society (MAPS) Annual Conference next week to meet with clients, partners and collaborators. We look forward to discussing ground breaking solutions around our proprietary Integrated Patient Data™ and Medically Smart AI™. We look forward to exchanging perspectives on how Medical Affairs […]
Learnings from HIMMS Global Health Conference 2024
Over 35,000 leaders from 30 different countries are attending HIMSS Global Health Conference & Exhibition, which kicked off on March 11th and will continue to inspire until March 15th. Clinakos Inc. is thrilled to be part of this action. Meanwhile, here are a few themes we have seen at the conference and our meetings at […]
ViVE Conference 2024
The ViVE conference concluded last week with significant enthusiasm surrounding the latest advancements in healthcare. At the core of the conference, there was a strong commitment to integrating data, AI, and ethical principles. Industry leaders, practitioners, and innovators converged to explore the intersection of these forces, shaping the future of healthcare. From personalized care to […]
Clinakos Supports Rare Disease Day
Cumulatively, there are more than 10,000 rare diseases affecting over 30 million Americans. 70% of these diseases begin in childhood, and 72% of them have a genetic basis. Additionally, nearly 1 out of 5 cancers is considered rare. Unfortunately, many rare disease patients face significant challenges before receiving a proper diagnosis, and even after diagnosis, […]
Meet us at 20th Annual World Symposium 2024
Feeling incredibly energized at the World Symposium (20th Annual World Symposium 2024) in San Diego. The passion and dedication of everyone involved in Lysosomal Diseases research is truly inspiring.This year’s event dived into a diverse range of Lysosomal disorders including Fabry, Pompe, Gaucher and MLD, understanding the underlying mechanisms of diseases to developing effective treatments.Several amazing […]
Meet us at JP Morgan Chase & Co.’s 42nd Annual JP Morgan Healthcare Conference
Clinakos Inc. will be at JPM2024 meeting clients, collaborators and industry colleagues to kick off a great 2024! We continue to be passionate about leveraging Patient Data and AI to further the progress in life sciences and healthcare. Reach out if you want to connect.
How Digital Twins are Reshaping Healthcare and Pharma
McKinsey & Company research indicates that 70% of C-suite technology executives at large enterprises are already exploring and investing in digital twins. Interest in digital twins, combined with rapidly advancing supportive technologies, is spurring market estimates for digital-twin investments of more than $48 billion by 2026. Patient Digital Twins are now reshaping healthcare and pharma through their […]
